Please ensure Javascript is enabled for purposes of website accessibility

Corporation for Public Broadcasting to Close After Funding Cut, in Blow to Local Media

8 hours ago

‘Freedom Week’: California Gun Owners Rush to Buy Ammo After Court Ruling

11 hours ago

Wall Street Selloff Sparked by Trump Tariffs, Amazon Results, Weak Payrolls

11 hours ago

US Construction Spending Extends Decline in June

12 hours ago

Global Shares in Red After US Jobs Data, Trump’s Tariff Salvo

12 hours ago

Construction of $200M Trump Ballroom at the White House to Begin in September

1 day ago

US Senate Committee Backs $1 Billion for Ukraine in Pentagon Spending Bill

1 day ago

Trump Says Mexico Trade Deal Extended for 90 Days

1 day ago

Fresno Unified Trustee Susan Wittrup Responds to $162,000 Payout

2 days ago
US to Resume J&J COVID Vaccinations Despite Rare Clot Risk
gvw_ap_news
By Associated Press
Published 4 years ago on
April 24, 2021

Share

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot.

The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot. All were women, most under age 50. Three died, and seven remain hospitalized.

But ultimately Friday, the Food and Drug Administration and Centers for Disease Control and Prevention decided that J&J’s one-and-done vaccine is critical to fight the pandemic — and that the small clot risk could be handled with warnings to help younger women decide if they should use that shot or an alternative.

“Above all else, health and safety are at the forefront of our decisions,” CDC Director Dr. Rochelle Walensky said in a statement. “Our vaccine safety systems are working. We identified exceptionally rare events – out of millions of doses” of the J&J shot and will continue to monitor them.

Concerns About the Risk in Certain Age Groups of Women

The U.S. decision — similar to how European regulators are rolling out J&J’s shot — comes after CDC advisers earlier Friday voted 10-4 to resume vaccinations but panelists made clear that they must come with warnings about the risk. The group debated but ultimately steered clear of outright age restrictions.

“This is an age group that is most at risk (of the clotting) that is getting vaccine predominately to save other peoples’ lives and morbidity, not their own. And I think we have a responsibility to be certain that they know this,” said Dr. Sarah Long of Drexel University College of Medicine, who voted against the proposal because she felt it did not go far enough in warning women.

The committee members all agreed the J&J vaccine “should be put back into circulation,” panel chairman Dr. Jose Romero, Arkansas’ health secretary, said in an interview after the vote. “The difference was how you convey the risk … It does not absolve us from making sure that people who receive this vaccine, if they are in the risk group, that we inform them of that.”

European regulators earlier this week made a similar decision, deciding the clot risk was small enough to allow the rollout of J&J’s shot. But how Americans ultimately handle J&J’s vaccine will influence other countries that don’t have as much access to other vaccination options.

Dr. Paul Stoffels, J&J’s chief scientific officer, pledged that the company would work with U.S. and global authorities “to ensure this very rare event can be identified early and treated effectively.” J&J already was working with the FDA on a warning label for the shot.

Rare Blood Clot Cases

At issue is a weird kind of blood clot that forms in unusual places, such as veins that drain blood from the brain, and in patients with abnormally low levels of the platelets that form clots. Symptoms of the unusual clots, dubbed “thrombosis with thrombocytopenia syndrome,” include severe headaches a week or two after the J&J vaccination — not right away — as well as abdominal pain, nausea.

The government initially spotted six cases of the rare clots, with nine more cases coming to light in the last week or so. But even the first needle-in-a-haystack reports raised alarm because European regulators already had uncovered similar rare clots among recipients of another COVID-19 vaccine, from AstraZeneca. The AstraZeneca and J&J shots, while not identical, are made with the same technology.

European scientists found clues that an abnormal platelet-harming immune response to AstraZeneca’s vaccine might be to blame — and if so, then doctors should avoid the most common clot treatment, a blood thinner called heparin.

That added to U.S. authorities’ urgency in pausing J&J vaccinations so they could tell doctors how to diagnose and treat these rare clots. Six patients were treated with heparin before anyone realized that might harm instead of help.

Determining if the Benefits Outweigh the Risks

Dr. Jesse Goodman of Georgetown University closely watched Friday’s deliberations and said people should be made aware of the clotting risk but that it shouldn’t overshadow the benefits of COVID-19 protection.

“We need to treat people as adults, tell them what the information is and give them these choices,” said Goodman, a former vaccine specialist at the FDA.

Two-dose vaccines from Pfizer and Moderna, which are made differently and haven’t been linked to clot risks, are the mainstay of the U.S. vaccination effort. But many states had been counting on the easier-to-store, one-and-done option to also help protect hard-to-reach populations including people who are homeless or disabled.

The CDC’s advisers struggled to put the rare clot cases into perspective. COVID-19 itself can cause a different type of blood clots. So can everyday medications, such as birth control pills.

The side effect debate isn’t the only hurdle facing J&J. The FDA separately uncovered manufacturing violations at a Baltimore factory the company had hired to help brew the vaccine. No shots made by Emergent BioSciences have been used — J&J’s production so far has come from Europe. But it’s unclear how the idled factory will impact J&J’s pledge to provide 100 million U.S. vaccine doses by the end of May and 1 billion doses globally this year.

RELATED TOPICS:

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

US Judges Speak Out About Death Threats, ‘Swattings,’ and ‘Pizza Doxings’

DON'T MISS

It’s Raining Cash for Some 2026 Fresno City Council Hopefuls

DON'T MISS

Fresno County Finds E. Coli at Avocado Lake. Don’t Swim There

DON'T MISS

Trump Fires US Labor Department’s Statistical Leader After Weaker Than Expected Jobs Report

DON'T MISS

Corporation for Public Broadcasting to Close After Funding Cut, in Blow to Local Media

DON'T MISS

Trump Eyes Bringing Azerbaijan, Central Asian Nations Into Abraham Accords, Sources Say

DON'T MISS

Farmers in West Fresno County to Consider 200% Groundwater Pumping Fee Hike

DON'T MISS

Trump Orders Nuclear Submarines Moved Near Russia

DON'T MISS

Fresno Councilmember Vang Accused of Conflict of Interest in Budget Vote

DON'T MISS

Ghislaine Maxwell Moved From Florida Prison to Lower-Security Facility

UP NEXT

Trump Fires US Labor Department’s Statistical Leader After Weaker Than Expected Jobs Report

UP NEXT

Trump Eyes Bringing Azerbaijan, Central Asian Nations Into Abraham Accords, Sources Say

UP NEXT

Trump Escalates Trade War With Canada Following Palestine Stance

UP NEXT

US Construction Spending Extends Decline in June

UP NEXT

Countries With No Trade Deal Will Hear From US by Midnight, White House Says

UP NEXT

Construction of $200M Trump Ballroom at the White House to Begin in September

UP NEXT

US Senate Committee Backs $1 Billion for Ukraine in Pentagon Spending Bill

UP NEXT

Trump Says Mexico Trade Deal Extended for 90 Days

UP NEXT

Judges Question Whether Trump Tariffs Are Authorized by Emergency Powers

UP NEXT

US Treasury Chief Says He Expects Fed Chair Announcement by Year’s End

Trump Fires US Labor Department’s Statistical Leader After Weaker Than Expected Jobs Report

7 hours ago

Corporation for Public Broadcasting to Close After Funding Cut, in Blow to Local Media

8 hours ago

Trump Eyes Bringing Azerbaijan, Central Asian Nations Into Abraham Accords, Sources Say

8 hours ago

Farmers in West Fresno County to Consider 200% Groundwater Pumping Fee Hike

9 hours ago

Trump Orders Nuclear Submarines Moved Near Russia

9 hours ago

Fresno Councilmember Vang Accused of Conflict of Interest in Budget Vote

10 hours ago

Ghislaine Maxwell Moved From Florida Prison to Lower-Security Facility

10 hours ago

Trump Escalates Trade War With Canada Following Palestine Stance

10 hours ago

Valley Crime Stoppers’ Most Wanted Person of the Day: Scott Oscar Whitehead

11 hours ago

‘Freedom Week’: California Gun Owners Rush to Buy Ammo After Court Ruling

11 hours ago

US Judges Speak Out About Death Threats, ‘Swattings,’ and ‘Pizza Doxings’

United States judges spoke out against the unprecedented surge in violence and disturbing threats made against members of the judicial branc...

5 hours ago

United States judges speaking about receiving violent threats over rulings
5 hours ago

US Judges Speak Out About Death Threats, ‘Swattings,’ and ‘Pizza Doxings’

Fresno city hall with council campaign finance money
6 hours ago

It’s Raining Cash for Some 2026 Fresno City Council Hopefuls

E. coli identified at avocado lake
7 hours ago

Fresno County Finds E. Coli at Avocado Lake. Don’t Swim There

President Donald Trump speaks at a dinner with Republican Senators, in the State Dining Room at the White House in Washington, D.C., U.S., July 18, 2025. (Reuters File)
7 hours ago

Trump Fires US Labor Department’s Statistical Leader After Weaker Than Expected Jobs Report

Breaking News from Reuters
8 hours ago

Corporation for Public Broadcasting to Close After Funding Cut, in Blow to Local Media

President Donald Trump delivers remarks in the Roosevelt Room at the White House in Washington, D.C., U.S., July 31, 2025. (Reuters File)
8 hours ago

Trump Eyes Bringing Azerbaijan, Central Asian Nations Into Abraham Accords, Sources Say

9 hours ago

Farmers in West Fresno County to Consider 200% Groundwater Pumping Fee Hike

President Donald Trump speaks after disembarking Marine One, as he departs for Scotland, at Joint Base Andrews, Maryland, U.S., July 25, 2025. (Reuters/Evelyn Hockstein)
9 hours ago

Trump Orders Nuclear Submarines Moved Near Russia

Help continue the work that gets you the news that matters most.

Search

Send this to a friend